CME Group Inc.: financial analysis
Ratios worked out from 10 fiscal years of CME Group Inc.'s statements, compared with 13 companies in Financial Data and Stock Exchanges.
CME Group Inc. scorecard#
Passes 14 of the 21 checks that could be worked out: strongest in growth (5 of 6), weakest in valuation (2 of 5). Fiscal year 2025; market cap of Oct 30, 2026.
Valuation2 of 5
- ✓P/E below its peers' median24.0×P/E 24.0× against Financial Data and Stock Exchanges's median of 27.2×.
- ✓Price to book below its peers' median3.7×Price to book 3.7× against Financial Data and Stock Exchanges's median of 4.8×.
- ✗Price to sales below its peers' median15.2×Price to sales 15.2× against Financial Data and Stock Exchanges's median of 9.8×.
- ✗Free cash flow yield above 5%4.0%Free cash flow is 4.0% of the market value.
- ✗Earnings yield above the 10-year Treasury yield4.2%Earnings yield 4.2% against the 10-year Treasury's 5.15% on 2026-11-13.
- –The price assumes slower growth than the last three years'Not worked out for banks and insurers.
Growth5 of 6
- ✓Revenue grew in the newest year6.4%Revenue up 6.4% in fiscal 2025.
- ✓Revenue up more than 5% a year over three years9.1%9.1% a year over the three years to fiscal 2025.
- ✗Faster growth over three years than its peers' median9.1%9.1% a year against Financial Data and Stock Exchanges's median of 9.3% (11 companies).
- ✓Earnings per share grew in the newest year11.16 vs 9.67Diluted EPS 11.16 in fiscal 2025 against 9.67 the year before (report's currency).
- ✓Net income higher than five years earlier$4.1 B$4.1 B in fiscal 2025 against $2.1 B in 2020.
- ✓Revenue rose in at least four of the last five years4 of 5Revenue rose in 4 of the five years to fiscal 2025.
Profitability2 of 3
- ✓Profitable in the newest year$4.1 BNet income $4.1 B in fiscal 2025.
- ✓Profitable in each of the last five years5 of 5Profitable in 5 of the five years to fiscal 2025.
- –Operating margin above its peers' medianNot worked out for banks and insurers.
- ✗Return on equity above 15%14.8%14.8% in fiscal 2025.
- –Return on invested capital above 10%Not worked out for banks and insurers.
- –Operating margin wider than three years earlierNot worked out for banks and insurers.
Financial health1 of 1
- –Short-term assets cover short-term liabilitiesNot worked out for banks and insurers.
- –Debt below equityNot worked out for banks and insurers.
- –Net debt below three years of EBITDANot worked out for banks and insurers.
- –Operating income covers interest five timesNot worked out for banks and insurers.
- –Cash from operations positive in each of the last three yearsNot worked out for banks and insurers.
- –Altman Z-score outside the distress zoneNot worked out for banks and insurers.
- ✓Equity at least 8% of assets14.5%Equity is 14.5% of assets at the end of fiscal 2025.
Shareholder returns4 of 6
- ✓Pays a dividendYesPaid dividends in fiscal 2025.
- ✗Dividend per share raised five years in a row3 of 5Dividend per share raised in 3 of the five years to fiscal 2025.
- ✗Dividends under 75% of net income96.6%Dividends were 96.6% of net income in fiscal 2025.
- ✓Share count up no more than 2% in a year0.1%Diluted shares up 0.1% in fiscal 2025.
- ✓Dividends and buybacks above 3% of the market value3.7%Dividends and buybacks were 3.7% of the market value.
- ✓Free cash flow covers dividends and buybacks$4.2 BFree cash flow $4.2 B against $3.9 B paid out in fiscal 2025.
Worked out from the statements as filed (sec), the medians of Financial Data and Stock Exchanges, the 10-year Treasury yield of Nov 13, 2026 and the market cap. A check that cannot be worked out counts neither way. A reading aid, not advice. How the checks work
What the 2025 statements show#
Each line is an observation with its numbers, not a judgement of the company.
Strengths
- Revenue has grown 4 years in a row.
- Free cash flow has been positive 17 years in a row.
Profitability#
| Fiscal year | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | Median of peers | Ahead of |
|---|---|---|---|---|---|---|---|---|
| Return on equity | 14.8% | 13.3% | 12.0% | 9.9% | 9.8% | 15.3% | 40% | |
| Return on assets | 2.4% | 2.6% | 2.1% | 1.5% | 1.6% | 7.4% | 33% |
Growth#
| Fiscal year | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | Median of peers | Ahead of |
|---|---|---|---|---|---|---|---|---|
| Revenue growth | 6.4% | 9.9% | 11.2% | 7.0% | -4.0% | 8.1% | 8% | |
| Revenue growth, 3 years a year | 9.1% | 9.3% | 4.5% | 1.0% | 2.9% | 9.3% | 40% | |
| Revenue growth, 5 years a year | 6.0% | 4.7% | 5.3% | 6.6% | 5.5% | 8.9% | 10% | |
| Net income growth | 15.5% | 9.3% | 19.9% | 2.1% | 25.2% | 15.8% | 45% | |
| Earnings per share growth | 15.4% | 9.1% | 19.7% | 1.5% | 24.2% | 18.7% | 30% |
Financial strength#
| Fiscal year | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | Median of peers | Ahead of |
|---|---|---|---|---|---|---|---|---|
| Equity share of assets | 14.5% | 19.3% | 20.6% | 15.4% | 13.9% | 25.6% | 33% |
How each figure is worked out#
- Return on equity
- Net income as a share of shareholders' equity (the average of the start and the end of the year). Not given when equity is negative.
- Return on assets
- Net income as a share of total assets (average of the year).
- Revenue growth
- Revenue against the year before.
- Revenue growth, 3 years a year
- The yearly rate that takes revenue of three years earlier to this year's.
- Revenue growth, 5 years a year
- The yearly rate that takes revenue of five years earlier to this year's.
- Net income growth
- Net income against the year before. Only when both years were profitable.
- Earnings per share growth
- Diluted earnings per share against the year before. Only when both were positive.
- Equity share of assets
- Shareholders' equity as a share of total assets.
- Dividend yield
- Dividends paid in the fiscal year as a share of today's market value.
- Shareholder yield
- Dividends plus buybacks as a share of today's market value.
- Dividend payout
- Dividends paid as a share of net income. Only when the year was profitable.
- Change in share count
- Diluted shares against the year before. Negative: fewer shares.
Source: CME Group Inc.'s statements: annual reports filed with the SEC. Arithmetic on reported figures, in US dollars; nothing is estimated. A figure is blank when a line it needs is not in the statements on file, and left out when the result cannot be right (a margin from next to no revenue). For a bank or insurer the margin, debt, liquidity and cash-flow ratios and the two scores are not worked out: its statements have no such lines. "Ahead of" is the share of the 13 companies in Financial Data and Stock Exchanges that CME Group Inc. is better than on that figure, using each company's newest fiscal year; yields use today's market value. Medians for every industry · Back to CME Group Inc.